The GHSC-PSM team is currently developing our annual strategic sourcing plan to procure Antiretroviral Drugs (ARVs) for fiscal year 2024 (FY24). The period of the strategy is November 2023 to November 2024. This strategy shall emphasize ARV commodity security, market health, long-term sustainability, a continuation of promoting USAID private sector engagement objectives and for the first time, subject to USAID making adjustments to its policies, procurement from eligible African sources. The purpose of this document is to share an overview of the sourcing strategies under consideration. It also serves as an advance notice to ARV suppliers to make necessary preparations in anticipation of the forthcoming release of the FY24 Request for Proposals (RFP).
